TIDMKNB
RNS Number : 6041E
Kanabo Group PLC
30 June 2023
30 June 2023
Kanabo Group Plc
("Kanabo" or the "Company")
Result of AGM
Kanabo Group Plc (LSE:KNB), the patient focused healthcare
technology and medicinal cannabis company, announces that at the
Annual General Meeting ("AGM") held earlier today thirteen
resolutions were duly passed. The numbers of votes for each
resolution are presented below:
Resolution Total For (i) Total Against Withheld (ii)
(No. as noted
on proxy form)
No. of % of No. of % of No. of votes
votes vote votes vote
------------ ------- ----------- ------- --------------
Resolution
1 231,148,817 99.93% 162,363 0.07% 74,145
------------ ------- ----------- ------- --------------
Resolution
2 230,958,946 99.90% 230,317 0.10% 196,062
------------ ------- ----------- ------- --------------
Resolution
3 161,657,876 99.88% 197,595 0.12% 69,529,854
------------ ------- ----------- ------- --------------
Resolution
4 223,079,901 96.45% 8,201,867 3.55% 103,557
------------ ------- ----------- ------- --------------
Resolution
5 223,081,901 96.46% 8,198,729 3.54% 104,695
------------ ------- ----------- ------- --------------
Resolution
6 223,091,027 96.46% 8,189,603 3.54% 104,695
------------ ------- ----------- ------- --------------
Resolution
7 231,103,813 99.91% 199,779 0.09% 81,733
------------ ------- ----------- ------- --------------
Resolution
8 223,053,034 96.44% 8,245,185 3.56% 87,106
------------ ------- ----------- ------- --------------
Resolution
9 (iii) 153,592,369 66.41% 77,697,479 33.59% 95,477
------------ ------- ----------- ------- --------------
Resolution
10 231,033,085 99.86% 313,000 0.14% 39,240
------------ ------- ----------- ------- --------------
Resolution
11 (iii) 223,042,578 96.41% 8,303,507 3.59% 39,240
------------ ------- ----------- ------- --------------
Resolution
12 222,934,014 96.41% 8,304,818 3.59% 146,493
------------ ------- ----------- ------- --------------
Resolution
13 231,033,617 99.89% 254,406 0.11% 97,302
------------ ------- ----------- ------- --------------
Resolution
14 (iii) 223,042,110 96.41% 8,302,150 3.59% 41,065
------------ ------- ----------- ------- --------------
(i) The "For" Proxy vote includes those giving the Chair of the AGM discretion
(ii) A vote "Withheld" is not a vote in law and is not included
in the proxy votes "For" or "Against" the resolution
(iii) Special resolution
The full text of the resolutions can be found in the Notice of
Annual General Meeting, which is available on the Company's website
at: https://www.kanabogroup.com/investors/
For further information, please visit
http://www.kanabogroup.com/ or contact the following:
Enquiries:
Kanabo Group plc via Vigo Consulting
Avihu Tamir, Chief Executive Officer +44 (0)20 7390 0230
Assaf Vardimon, Chief Financial Officer
Ian Mattioli, Non-Executive Chair of the
Board
Peterhouse Capital Ltd (Financial Adviser
and Broker)
Eran Zucker/ Lucy Williams / Charles Goodfellow +44 (0)20 7469 0930
Vigo Consulting (Financial Public Relations/Investor
Relations)
Jeremy Garcia / Fiona Hetherington / Verity
Snow +44 (0)20 7390
kanabo@vigoconsulting.com 0230
About Kanabo Group Plc
Kanabo Group Plc (LSE:KNB) is a healthtech company committed to
revolutionising patient care through its innovative technology
platform and disruptive product offerings. Since its inception in
2017, Kanabo has been focused on researching, developing, and
commercialising regulated medicinal cannabis-derived formulations
and therapeutic inhalation devices.
Kanabo's NHS-approved online telehealth platform, The GP
Service, provides patients with video consultations, online
prescriptions, and primary care services. The Company is a leader
in its field, focusing on improving patient outcomes and providing
more accessible healthcare experiences.
In March 2023, Kanabo successfully launched its Pain Clinic,
Treat It, under the expert guidance of its technological and
product expertise. Treat It initially focuses on chronic pain
management using plant-based medicine and treatments that are
currently unavailable through traditional channels.
At Kanabo Group Plc, we are dedicated to providing patients with
the highest quality medical treatments and more accessible
healthcare experiences.
Visit www.kanabogroup.com for more information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGEADKEDDFDEFA
(END) Dow Jones Newswires
June 30, 2023 09:34 ET (13:34 GMT)
Kanabo (LSE:KNB)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Kanabo (LSE:KNB)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
